Brevan Howard Capital Management »

Miragen Therapeutics shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $304k 16k 19.56
2025-12-31 $546k 18k 31.12
2024-12-31 $258k 14k 19.17

More positions owned by Brevan Howard Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr Iboxx Inv Cp Etf (LQD)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Pdd Holdings Sponsored Ads (PDD)
Ishares Tr China Lg-cap Etf (FXI)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr State Street Fin (XLF)
Agnc Invt Corp Com reit (AGNC)
Ishares Msci Brazil Etf (EWZ)
Meta Platforms Cl A (META)
Palantir Technologies Cl A (PLTR)

View all positions for Brevan Howard Capital Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Vanguard Group
Bellevue Group
Vanguard Capital Management
Fairmount Funds Management
VR Adviser
State Street Corporation
Paradigm Biocapital Advisors
Citadel Advisors
Kynam Capital Management
Geode Capital Management
Balyasny Asset Management
Novo A/S
Baker Bros. Advisors

View all funds holding Miragen Therapeutics